Keywords: vanda, shares, halve, iloperidone, setback, pharmaceuticals, lost

Vanda's shares halve on US iloperidone setback

Article | 04 August 2008

Print This

Shares in Vanda Pharmaceuticals lost half their value after US regulators rejected its schizophrenia drug iloperidone. The Food and Drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in